Molecular properties of artificial sweeteners in water

Cyril Rajnák *ab, Juraj Štofko b and Roman Boča *b
aFaculty of Natural Sciences, University of Ss Cyril and Methodius, Trnava, 91701, Slovakia. E-mail: cyril.rajnak@ucm.sk
bFaculty of Health Sciences, University of Ss Cyril and Methodius, Trnava, 91701, Slovakia

Received 1st September 2025 , Accepted 31st October 2025

First published on 3rd December 2025


Abstract

Currently, artificial sweeteners – saccharin, acesulfame, cyclamic acid, and aspartame – are used as food additives. These compounds in their molecular and ionised forms have been studied by quantum chemical methods: the B3LYP hybrid variant of density functional theory and the post-Hartree–Fock DLPNO-CCSD(T) method, which includes a major part of the electron correlation energy. Full geometry optimisation and vibrational analysis were performed using the B3LYP method for neutral molecules, their cations and their anions. For neutral molecules, calculated molecular properties include electronic, electrical, and thermodynamic properties. Calculated ionisation energies and electron affinities were used to predict redox properties – the absolute oxidation and reduction potentials. All data refer to water as a solvent. Three electron–proton transfer mechanisms were investigated for studied systems: (i) the SPLET (Sequential Proton Loss Electron Transfer) mechanism starts with proton transfer (deprotonation) and then continues with electron transfer (oxidation); (ii) the SET-PT (Single Electron Transfer followed by Proton Transfer) mechanism has interchanged steps, so that electron transfer is followed by proton transfer; and (iii) the HAT (Hydrogen Atom Transfer) mechanism assumes simultaneous oxidation and deprotonation. According to the reaction Gibbs energy (B3LYP) and/or total electronic energy (DLPNO-CCSD(T)), the SPLET mechanism is favoured. High ionisation energies prevent the functionality of studied artificial sweeteners as antioxidants.


Introduction

The consumption of sucrose (natural sugar) is still growing. This substance has both positive and negative effects on the human body. The positives are the high energy content, fast energy source and fast absorbability.1–10 The negative effects are, for example, diabetes mellitus, irreversible damage to teeth and obesity. Artificial sweeteners reduce the negative effects, and their sweetness significantly exceeds the sweetness of sucrose. However, their daily use can also cause prediabetes and can trigger other diseases.11–21 In one sentence, sugar substitutes belong to food additives that provide a sweetness effect; unlike sugar, they contain much less food energy (low-calorie or zero-calorie sweeteners). Depending on the source, they can be classified as plant extracts or products of chemical synthesis. A specific class consists of sugar alcohols, some with simple aliphatic structures, such as arabitol, erythritol, glycerol, mannitol, sorbitol and xylitol. The most used artificial sweeteners are (Table 1) 1H-1λ6,2-benzothiazole-1,1,3(2H)-trione – saccharin (E954),22,27 potassium 6-methyl-2,2-dioxo-2H-1,2λ6,3-oxathiazin-4-olate – acesulfame potassium (E950),23,28 sodium cyclohexylsulfamate – cyclamate (E952)24,29 and methyl L-α-aspartyl-L-phenylalaninate – aspartame (E951).25,26,30
Table 1 Structures of artificial sweetenersa
a For selected physicochemical properties, see Table S1.
image file: d5nj03504j-u1.tif


Saccharin is a cyclisation product that can be prepared by the following route: toluene → o-chlorosulfonic acid → o-sulfonamide → [oxidation] carboxylic acid → [cyclisation] saccharin. It is a white, thermally stable solid that is not very soluble in water, has an acidic N–H bond (Ka = 1.3), and is hydrophilic (log[thin space (1/6-em)]Pow = 0.9). It is odourless with negligible nutritional value. It is about 500 times sweeter than sucrose and is therefore used as a safe artificial sweetener for patients suffering from diabetes or prediabetes. It is applied in the form of sodium or calcium salts in drinks, pastries, and candies and as an additive to some medicines to cover their bitter taste. These salts are highly soluble in water: 0.67 g cm−3. It is often used in combination with other sweeteners such as cyclamate and aspartame.

Acesulfame is structurally closely related to saccharin but has a six-membered ring instead of a five-membered one. It has similar properties to saccharin: a white solid, thermally stable, soluble in water, with an acidic N–H bond (Ka = 2.0); it is hydrophobic (log[thin space (1/6-em)]Pow = −1.3). It is about 200 times sweeter than sucrose, which implies its usage as an artificial sweetener. At higher concentrations, it has a slightly bitter aftertaste. It is sold in the form of potassium salts and is often mixed with other artificial sweeteners, e.g., aspartame.

Cyclamic acid (cyclamate, cyclohexanesulfamic acid) also belongs to the family of compounds with the [double bond splayed left]SO2 group. This white, odourless solid is very water-soluble (1000 mg cm−3), stable when heated, and 30–50 times sweeter than sucrose. It is cheaper than most artificial sweeteners and is used in the form of the sodium or potassium salts.

Aspartame is a methyl ester of a dipeptide formed from L-asparatic acid and L-phenylalanine. Aspartame can undergo hydrolysis that is strongly dependent on pH: it is most stable at pH = 4.3 with a half-life of about 300 days. At pH = 7 its half-life is only a few days. Sweetened drinks have pH = 3–5. Under strongly acidic or basic conditions and upon digestion, aspartame is hydrolysed to aspartic acid, phenylalanine and methanol. High levels of phenylalanine can be hazardous for individuals suffering from phenylketonuria. Aspartame is about 180–200 times sweeter than sucrose. As a low-calorie sweetener, it is used to substitute sugar in beverages and foods, especially for patients suffering from diabetes. Aspartame is metabolised and absorbed very quickly and is not accumulated in the body. Aspartame crystallises in the zwitterion form; it forms aspartame hydrochloride, having an acidic carboxyl group (aspartamium).

Recent research on aspartame has focused on investigating the effects of its metabolites on the human brain.31 Also, long-term studies of people with diabetes who consumed artificial sweeteners have demonstrated measurable decline in cognitive functions.32,33 Moreover, animal studies administering aspartame have shown increased insulin release, contributing to atherosclerosis, memory deficits, and other complications.34,35

The aim of the quantum-chemical study is to characterise the redox properties of artificial sweeteners in water, such as absolute oxidation and reduction potentials, molecular electronegativity, chemical hardness, electrophilicity index, and mechanisms of electron–proton transfer –problems not studied so far.

Methods

The ORCA package was used for quantum-chemical calculations of the electronic structure and molecular properties of the studied molecules.36–38 Density functional theory with a hybrid variant B3LYP/UKS was used for full geometry optimisation followed by a complete vibrational analysis. The basis set of valence-triple-zeta-polarisation and diffuse functions quality (abbr. def2-TZVPD) was applied.39

The post-Hartree–Fock method, namely Domain Localised Pair Natural Orbitals – Coupled Cluster Singles + Doubles + perturbative Triples method, abbr. DLPNO-CCSD(T), has also been applied with the aug-cc-pVTZ (Dunning correlation consistent with Polarisation Valence Triple-Zeta, extended by diffusion functions) basis set;40,41 the UHF variant was applied for open shell systems. This method involves the main part of the electron correlation energy. A conductor-like polarisable continuum model (CPCM) was used to account for the solvent effect in water with relative permittivity εr = 80.1.42 Details of the method of calculations are presented in the SI.

Results and discussion

Molecular geometry

Geometry optimisation was performed by the B3LYP method for three classes of species: (i) canonical forms (C) of saccharin, acesulfame, cyclamic acid and aspartame; (ii) ionic forms of saccharinate, acesulfamate, cyclamate and aspartamium; and (iii) zwitterionic forms of cyclamic acid and aspartame. Each species was considered in three oxidation states: as a closed shell system L0, an oxidized form L+, and a reduced form L. A total of 30 molecules per molecular ions were processed. The final geometries are shown in Fig. S1–S3.

Saccharin and acesulfame do not have rotatable C–C bonds, so they do not have rotamers. Aspartame has 38 = 6561 rotamers. The calculated geometries for neutral molecules in water closely copy the solid-state structures determined by X-ray diffraction (Fig. 1 and Fig. S4).22–30


image file: d5nj03504j-f1.tif
Fig. 1 Overlaid structures of saccharine, acesulfame, cyclamic acid, and aspartame taken from solid-state X-ray diffraction (green) and B3LYP calculations in water (purple).

For neutral amino acids, the zwitterionic form is more stable in water compared to the canonical form by ΔE0 = 12.2 and ΔGø = 20.5 kcal mol−1 for cyclamic acid and ΔE0 = 4.2 and ΔGø = 3.2 kcal mol−1 for aspartame (B3LYP data). This is caused by the charge polarisation in the zwitterionic forms, which results in higher hydration energy: ΔECPCM = −48.1 (aspartame Z) vs. −23.4 kcal mol−1 (aspartame C) using B3LYP. The DLPNO-CCSD(T) method gave electron-correlated values of ΔE0 = 10.6 and 1.8 kcal mol−1 for cyclamic acid and aspartame, respectively. The stabilisation of the zwitterionic forms in the aqueous solution is a typical feature of amino acids.43,44

Vibrational spectra

Calculated unscaled vibrational transitions (harmonic approximation, B3LYP method) are presented in Fig. S5 for saccharine, sacchatinate (1−), acesulfame, acesulfamate (1−), cyclamic acid in canonical and zwitterionic forms, cyclamate (1−), aspartame in canonical and zwitterionic forms, and aspartamium (1+). All spectra show two domains: high-frequency referring to the valence vibrations (C–H, N–H, and O–H) in the region 2800–3700 cm−1 and low-frequency referring to the deformation vibrations below 1800 cm−1. The experimental data are also included for comparison.45–48 The calculated unscaled spectra are broader when compared to the highest stretching frequencies (O–H or N–H). The absence of the valence N–H vibrations in saccharinate (1−) and acefulfamate (1−) species is evident in the high-frequency domain. The effect of the scaling of the B3LYP calculated frequencies by a factor of 0.962 is demonstrated for aspartame.

Electron–proton transfer

The antioxidant activity of the species is usually accompanied by electron transfer coupled with proton transfer (removal). Three mechanisms have been proposed depending on the reaction steps: (i) The SPLET (sequential proton loss electron transfer) mechanism starts with proton transfer (deprotonation) and then continues with electron transfer (oxidation); (ii) the SET-PT (single electron transfer followed by proton transfer) mechanism has interchanged steps, so that electron transfer is followed by proton transfer; (iii) the HAT (hydrogen atom transfer) mechanism assumes the removal of a hydrogen atom, so the transfer of electrons and protons takes place in one step.49

Energy profiles for electron–proton coupled transfer are shown in Table 2 for saccharin, acesulfame, cyclamic acid and aspartamium. The reaction energy for proton transfer includes the energy of the hydrated hydrogen radical (H+)aq released; several values have been proposed, and “the best estimate” is ΔGø(H+)aq = −262 kcal mol−1.50 However, the calculated values are sensitive to the method used, and the value suitable for the B3LYP method is ΔGø(H+)aq = −274 kcal mol−1.51

Table 2 Energy profile for electron–proton coupled transfera
a Gibbs energies Gø refer to B3LYP calculations, and total electronic energies E0 to DLPNO-CCSD(T). For amino acids the canonical form is selected as a reference.
image file: d5nj03504j-u2.tif


Taking into account the release of (H+)aq, deprotonation of saccharin within the SPLET mechanism is associated with the Gibbs energy change Δd1G(corr) = 277 − 274 = 3 kcal mol−1. Compared to the second step – oxidation, for which Δo1G = 142 kcal mol−1, deprotonation is a much less energetically demanding process. The concurrent reaction through the SET-PT mechanism starts with an energy demand Δo2G = 170 kcal mol−1 and then with a release Δd2G(corr) = 248 − 274 = −26 kcal mol−1. Finally, the HAT mechanism requires the addition ΔHATG(corr) = 3 + 142 = 170 − 26 = 145 kcal mol−1. All these values refer to B3LYP calculations.

According to DLPNO-CCSD(T) calculations, the first deprotonation step within the SPLET mechanism of saccharin has Δd1E(corr) = 285 − 274 = 11 kcal mol−1 while the second step has Δd2E = 174 kcal mol−1. This is still more favourable compared to the SET-PT mechanism with steps Δo2E = 182 and Δd2E(corr) = 276 − 274 = 2 kcal mol−1 or ΔHATE(corr) = 184 kcal mol−1.

For acesulfame, Δd1G(corr) = 273 − 274 = −1, Δd2G = 146, ΔHATG(corr) = 145 kcal mol−1 by B3LYP, and Δd1E(corr) = 282 − 274 = 8, Δd2E = 156 kcal mol−1, ΔHATE(corr) = 164 kcal mol−1 by DLPNO-CCSD(T).

For cyclamic acid, Δd1G(corr) = 265 − 274 = −9 kcal mol−1, Δd2G = 131, ΔHATG(corr) = 122 kcal mol−1 by B3LYP, and Δd1E(corr) = 274 − 274 = 0, Δd2E = 143, ΔHATE(corr) = 143 kcal mol−1 by DLPNO-CCSD(T).

For the aspartame pathway, the starting point is aspartamium (1+) present in the hydrochloride salt. Then Δd1G(corr) = 274 − 274 = 0, Δd2G = 138, ΔHATG(corr) = 138 kcal mol−1 by B3LYP, and Δd1E(corr) = 285 − 274 = 11, Δd2E = 151, ΔHATE(corr) = 162 kcal mol−1 by DLPNO-CCSD(T).

As the steps in the energy profile of electron–proton transfer decrease, the hypothetical antioxidant capacity increases in the series of saccharin, acesulfame, aspartamium, and cyclamic acid. The above data refer to the thermodynamic predispositions for the oxidation of sweeteners (Fig. 2). (Kinetic studies will require identification of the transition state and evaluation of the activation Gibbs energy.)


image file: d5nj03504j-f2.tif
Fig. 2 Steps for oxidation (hydrogen atom removal) of studied sweeteners in water.

Molecular descriptors

The calculated molecular descriptors for electroneutral (reference) molecules are shown in Tables 3 and 4 for B3LYP calculations and in Tables 5 and 6 for DLPNO-CCSD(T) calculations.
Table 3 Molecular properties calculated by the B3LYP/def2-TZVPD method in watera
Molecule p −Q α S V E zpe STø
a All energy quantities in units of kcal mol−1; conversion: 1 hartree = 627.5095 kcal mol−1; 1 eV = 23.06054; 1 kcal mol−1 = 4.184 kJ mol−1. Standard temperature Tø = 298.15 K. Dipole moment p/debye; isotropic quadrupole moment Q/ea02, isotropic dipole polarisability α/a03, solvated surface area S/a02, solvated volume V/a03, debye, D = 3.336 × 10−30 A m s; angstrom, Å = 10−10 m; bohr, a0 = 5.292 × 10−11 m; zero-point energy Ezpe, total entropic term STø.
Canonical neutral forms
1C Saccharin 5.38 56.4 164.9 682 1248 72.5 28.2
2C Acesulfame 4.70 49.4 120.6 619 1085 63.1 27.6
3C Cyclamic acid 7.71 58.3 148.3 739 1336 126.3 30.2
4C Aspartame 3.02 87.2 277.8 1252 2347 197.4 44.4
Ionic forms
1I Saccharin-ate(−) (Na) 12.7 67.4 177.6 674 1247 64.8 27.7
2I Acesulfam-ate(−) (K) 9.81 58.2 132.0 613 1071 55.4 27.3
3I Cyclam-ate(−) (Na) 14.6 69.1 158.0 749 1331 118.9 29.8
4I Aspartamium(+) (Cl) 15.7 66.4 268.5 1246 2309 206.8 44.9
Zwitterionic forms
3Z Cyclamic acid 10.9 59.8 150.0 746 1354 127.9 29.9
4Z Aspartame 15.4 108.2 279.5 1234 2334 198.2 43.7


Table 4 Adiabatic redox properties calculated by the B3LYP/def2-TZVPD method in watera
Molecule E i E eg χ η ω E øox E øred
a Redox properties in kcal mol−1, ionisation energy Ei = E+E0, electron affinity Eeg = EE0, molecular electronegativity, chemical hardness, electrophilicity index, absolute oxidation potential Eøox = −ΔoxGø/F in V, absolute reduction potential Eøred = −ΔredGø/F in V, Faraday constant F = 96[thin space (1/6-em)]485 A s mol−1. n.a. – not available because of dissociation of the H atom for negatively charged cyclamic acid.
Canonical neutral forms
1C Saccharin 173.0 −62.3 117.7 55.4 125.0 −7.39 2.81
2C Acesulfame 166.5 −56.7 111.6 54.9 113.4 −7.14 2.57
3C Cyclamic acid 156.3 n.a. −6.68
4C Aspartame 139.2 −31.0 85.0 54.1 66.8 −5.99 1.44
Ionic forms
1I Saccharin-ate(−) (Na) 143.3 −44.7 94.0 49.3 89.6 −6.16 2.07
2I Acesulfam-ate(−) (K) 148.1 −36.6 92.4 55.8 76.5 −6.34 1.70
3I Cyclamate(−) (Na) 132.4 −10.8 71.6 60.8 42.2 −5.70 0.50
4I Aspartam-ium(+) (Cl) 152.1 −37.6 94.9 57.3 78.6 −6.54 1.73
Zwitterionic forms
3Z Cyclamic acid 175.2 −17.9 96.6 78.6 59.3 −7.40 0.94
4Z Aspartame 150.8 −31.7 91.3 59.6 69.9 −6.47 1.50


Table 5 Molecular properties calculated by the DLPNO-CCSD(T)/aug-cc-pVTZ method in watera
Molecule p Q S V HOMO LUMO
a Units as in Table 3. HOMO – highest occupied molecular orbital, LUMO – lowest unoccupied molecular orbital at the Hartree–Fock level.
Canonical neutral forms
1C Saccharin 6.163 57.0 682 1248 −233.6 19.1
2C Acesulfame 5.103 49.9 619 1085 −248.4 19.6
3C Cyclamic acid 8.108 58.5 739 1336 −258.6 20.4
4C Aspartame 2.728 86.9 1252 2347 −208.8 18.1
Ionic forms
1I Saccharin-ate(−) (Na) 13.76 67.8 674 1247 −221.1 20.4
2I Acesulfam-ate(−) (K) 10.52 58.4 613 1071 −229.2 21.1
3I Cyclamate(−) (Na) 15.43 68.1 710 1290 −239.8 21.6
4I Aspartam-ium(+) (Cl) 16.38 66.3 1246 2309 −216.2 16.1
Zwitterionic forms
3Z Cyclamic acid 11.23 60.1 746 1354 −273.8 20.7
4Z Aspartame 15.66 109.1 1234 2334 −209.4 17.9


Table 6 Adiabatic redox properties calculated by the DLPNO-CCSD(T)/aug-cc-pVTZ method in watera
Molecule E i E eg χ η ω

image file: d5nj03504j-t1.tif

image file: d5nj03504j-t2.tif

a Units as in Table 4.
Canonical neutral forms
1C Saccharin 182.4 −59.8 121.1 61.3 119.6 −7.91 2.59
2C Acesulfame 174.9 −54.7 114.8 60.1 109.6 −7.58 2.37
3C Cyclamic acid 168.6 n.a. −7.31
4C Aspartame 151.0 −28.5 89.7 61.2 65.8 −6.55 1.24
Ionic forms
1I Saccharin-ate(−) (Na) 173.6 −43.0 108.3 65.3 89.8 −7.53 1.86
2I Acesulfam-ate(−) (K) 156.4 −35.3 95.9 60.6 75.9 −6.78 1.53
3I Cyclamate(−) (Na) 143.4 −8.7 76.1 67.4 42.9 −6.22 0.38
4I Aspartam-ium(+) (Cl) 160.8 −35.6 98.2 62.6 77.0 −6.97 1.54
Zwitterionic forms
3Z Cyclamic acid 188.1 −17.4 102.7 85.3 61.9 −8.16 0.75
4Z Aspartame 160.4 −29.2 94.8 65.6 68.5 −6.96 1.27


These ground-state properties can be classified into two groups. Bulk properties increase with increasing molar mass of the molecule; in the series of acesulfame (2C), saccharin (1C), cyclamic acid (3C) and aspartame (4C), the solvated surface (and volume) increases as S = 619, 682, 739, and 1252a02 (and V = 1085, 1248, 1336, and 2347a03); the absolute value of the quadrupole moment (and dipole polarisability) varies as |Q| = 49, 56, 58, and 87ea02 (and α = 121, 165, 148, and 278a03); the zero-point vibration energy (and the total entropic term) increases as Ezpe = 63, 72, 126, and 197 (and STø = 27.6, 28.2, 30.1, and 44.4) kcal mol−1. The dipole moment shows no systematic trend (p = 4.70, 5.38, 7.71, and 3.02 debye) because it depends on the spatial separation of barycentres of negative and positive charges.

The second class of molecular descriptors refer to global properties such as energies of frontier orbitals (HOMO and LUMO) and the adiabatic redox properties (ionisation energy Ei, electron affinity Eeg, chemical hardness η, molecular electronegativity χ, electrophilicity index ω, absolute oxidation Eøox and reduction Eøred potentials).

While the chemical hardness of the studied molecules is approximately the same (η ∼ 55 kcal mol−1), aspartame shows the lowest electronegativity (χ = 85 kcal mol−1) and the lowest electrophilicity (ω = 67 kcal mol−1).

The zwitterionic forms of cyclamic acid (3Z) and aspartame (4Z) exhibit an increased dipole moment (p = 10.89 and 15.37 debye); bulk molecular properties remain close to their canonical forms. The ionisation energy is slightly higher for 4Z compared to 4C: 151 vs. 139 kcal mol−1 by B3LYP and 160 vs. 151 kcal mol−1 by DLPNO-CCSD(T).

Ionic forms carrying negative charge (1I, 2I, 3I) have lower ionisation energies compared to neutral prototypes; in contrast, aspartamium has the lowest ionisation energy.

Redox properties

The properties associated with redox processes were evaluated in the adiabatic way – after the complete geometry optimisation of the neutral and ionised species. These are also collected in Tables 3 and 4. The adiabatic ionisation energy based on the difference in electronic energies decreases in the order of the canonical forms saccharin (C1), acesulfame (C2), cyclamic acid (C3) and aspartame (C4) between Ei = 173–139 kcal mol−1 (B3LYP values). The ionization energy predetermines the reaction Gibbs energy for oxidation, ΔoxGøEi, which in turn relates to the absolute oxidation potential, Eøox = –ΔoxGø/F (F – Faraday constant). Therefore, the absolute oxidation potential correlates with the adiabatic ionisation energy along a straight line – see Fig. 3.
image file: d5nj03504j-f3.tif
Fig. 3 Correlation of the absolute oxidation potential with the adiabatic ionisation energy (left) and the absolute reduction potential with the electrophilicity index; linear equation y = b0 + b1x.

Data on ionisation energies can be classified into three groups. (i) 17 amino acids (glycine, α-alanine, GABA, DAVA, β-alanine, valine, leucine, isoleucine, AABA, BABA, AAIBA, BAIBA, hydroxyglycine, hydroxyalanine, serine, threonine, and homoserine) in their 34 forms (canonical C and zwitterionic Z) cover the interval of ionisation energies between 133 (DAVA, Z) and 155 (hydroxyglycine, Z) kcal mol−1. (ii) Five dopaminergic molecules (dopamine, noradrenaline, adrenaline, DOPA, and tyrosine) in their 10 forms (canonical C and zwitterionic Z) have ionisation energies between 98 (dopamine Z) and 137 (tyrosine Z) kcal mol−1. Low Ei values predispose the functionality of dopaminergic molecules as effective antioxidant agents.

(iii) Four artificial sweeteners (saccharin, acesulfame, cyclamic acid, and aspartame) in their 10 forms (canonical C, 2 zwitterionic Z, and 4 ionic I) have ionisation energies between 139 (aspartame, C) and 175 (cyclamic acid, Z) kcal mol−1. High Ei values prevent the functionality of artificial sweeteners as antioxidants. On the other hand, they can be considered as substances stable against oxidation.

Molecular electrostatic potential for the neutral molecules is plotted in Fig. 4. Molecules 1C, 2C and 3C show two charged regions: a negative one, which is spread over the O2S–NH–C(O) backbone, and a positive one involving the carbon and hydrogen atoms of a ring. In contrast, aspartame has three domains of negative charge.


image file: d5nj03504j-f4.tif
Fig. 4 Molecular electrostatic potential drawn at the isosurface electron density for 1C, 2C, 3C, 4C, 3Z and 4Z (in the reading direction). Red – negative, blue – positive.

Conclusions

Four commonly used artificial sweeteners – saccharin, acesulfame, cyclamic acid and aspartame – were investigated by quantum-chemical computational methods. The B3LYP method was used to optimise the geometry of the neutral and ionised species (cations and anions). The optimised geometries in water copy the solid-state structure obtained by X-ray diffraction.

Some molecular properties of neutral molecules increase with increasing molar mass: solvated surface and volume, electric quadrupole moment, dipole polarisability, zero-point vibration energy and total entropic term.

The absolute oxidation potentials of the investigated species are too negative; therefore, they do not act as antioxidants and are redox stable.

According to the reaction Gibbs energy, hydrogen transfer occurs preferentially in the two-step SPLET mechanism (deprotonation, followed by oxidation), compared to the alternative SET-PT mechanism (oxidation and then deprotonation).

Within the series of electroneutral sweeteners, aspartame has the lowest ionisation energy compared to three sulphur-containing molecules.

The zwitterionic forms of cyclamic acid and aspartame are more stable in water compared to the canonical forms due to the increased hydration energy.

The ionised (hydrogen-deficient) forms of saccharinate, acesulfamate and cyclamate exhibit lower ionisation energies, while the aspartamium possesses increased ionisation energy compared to electroneutral molecules.

The calculated absolute oxidation potentials correlate with the ionisation energies along a straight line (r2 = 0.997). Analogously, the correlation of absolute reduction potentials with the electrophilicity indices is proven.

The results obtained by the highly correlated DLPNO-CCSD(T) method are qualitatively the same as those obtained by B3LYP; however, they are quantitatively much more reliable.

Author contributions

C. R. wrote the core of the manuscript and discussion. J. S. wrote a part of the manuscript. including the literature search. R. B. did quantum chemical calculations by DLPNO-CCSD(T) methods and made figures. All authors reviewed the manuscript.

Conflicts of interest

There are no conflicts to declare.

Data availability

Computer protocols are available from the corresponding author upon request.

Supplementary information (SI): details about the methods, calculated total energies, figures of optimised structures, and calculated vibrational transitions. See DOI: https://doi.org/10.1039/d5nj03504j.

Acknowledgements

The Slovak grant agency VEGA (project 1/0191/22) is acknowledged for the financial support.

Notes and references

  1. T. A. Khan, J. J. Lee, S. Ayoub-Charette, J. C. Noronha, N. McGlynn, L. Chiavaroli and J. L. Sievenpiper, Eur. J. Clin. Nutr., 2023, 77, 1009 CrossRef PubMed.
  2. Artificial sweeteners. Meyler's Side Effects of Drugs, in The International Encyclopedia of Adverse Drug Reactions and Interactions, ed. J. K. Aronson, Elsevier, 16th edn, 2016, p. 713 Search PubMed.
  3. M. C. Yebra-Biurrun, Sweeteners, in Encyclopedia of Analytical Science, ed. P. Worsfold, A. Townshend and C. Poole, Elsevier, 2nd edn, 2005, p. 562 Search PubMed.
  4. J. F. Lawrence, Cyclamates, in Encyclopedia of Food Sciences and Nutrition, ed. B. Caballero, Elsevier, 2nd edn, 2003, p. 1712 Search PubMed.
  5. M. J. Prival, Cancer-Carcinogens in the Food Chain, in Encyclopedia of Food Sciences and Nutrition, ed. B. Caballero, Elsevier, 2nd edn, 2003, p. 799 Search PubMed.
  6. S. Pavanello, A. Moretto, C. La Vecchia and G. Alicandro, Regul. Toxicol. Pharmacol., 2023, 139, 105369 CrossRef CAS PubMed.
  7. K. Jorge, Soft drinks-Chemical Composition, in Encyclopedia of Food Sciences and Nutrition, ed. B. Caballero, Elsevier, 2nd edn, 2003, p. 5346 Search PubMed.
  8. K. Walton, R. Walker, J. J. M. van de Sandt, J. V. Castell, A. G. A. A. Knapp, G. Kozianowski, M. Roberfroid and B. Schilter, Food Chem. Toxicol., 1999, 37, 1175 CrossRef CAS PubMed.
  9. R. A. Lawrence and R. M. Lawrence, Maternal Nutrition and Supplements for Mother and Infant, Breastfeeding, Elsevier, 7th edn, 2011, p. 283 Search PubMed.
  10. A. R. Lobach, A. Roberts and I. R. Rowland, Food Chem. Toxicol., 2019, 124, 385 CrossRef CAS PubMed.
  11. A. Otabe, F. Ohta, A. Takumi and B. Lynch, Regul. Toxicol. Pharmacol., 2019, 103, 345 CrossRef CAS PubMed.
  12. S. A. Elmore, J. E. Rehg, T. R. Schoeb, J. I. Everitt and B. Bolon, Food Chem. Toxicol., 2023, 171, 113504 CrossRef CAS PubMed.
  13. D. Kirkland and D. Gatehouse, Food Chem. Toxicol., 2015, 84, 161 CrossRef CAS PubMed.
  14. M. Marinovich, C. L. Galli, C. Bosetti, S. Gallus and C. La Vecchia, Food Chem. Toxicol., 2013, 60, 109 CrossRef CAS PubMed.
  15. C. Wöber and Ç. Wöber-Bingöl, Handb. Clin. Neurol., 2010, 97, 161 Search PubMed.
  16. R. C. Guy, Aspartame, in Encyclopedia of Toxicology, ed. P. Wexler, Elsevier, 4th edn, 2024, 1, p. 835 Search PubMed.
  17. S. J. Borghoff, S. S. Cohen, X. Jiang, I. A. Lea, W. D. Klaren, G. A. Chappell, J. K. Britt, B. N. Rivera, N. Y. Choski and D. S. Wikoff, Food Chem. Toxicol., 2023, 172, 113549 CrossRef CAS PubMed.
  18. S. Yalamanchi, R. Srinath, A. Dobs and K. Acesulfame, in Encyclopedia of Food and Health, ed. B. Caballero, P. M. Finglas and F. Toldrá, 2016, p. 1 Search PubMed.
  19. M. Carocho, P. Morales and I. C. F. R. Ferreira, Food Chem. Toxicol., 2017, 107, 302 CrossRef CAS PubMed.
  20. J. R. Araújo, F. Martel and E. Keating, Reprod. Toxicol., 2014, 49, 196 CrossRef PubMed.
  21. C. Fitch, Saccharin – How Sweet It Is, in Encyclopedia of Food and Health, ed. B. Caballero, P. M. Finglas, F. Toldrá, 2016, p. 659 Search PubMed.
  22. CCDC 274592 (SCCHRN02): J. L. Wardell, J. N. Low and G. Glidewell, Acta Crystallogr., Sect. E: Struct. Rep. Online, 2005, 61, o1944 CrossRef CAS.
  23. CCDC 1211737 (MGSACD10), G. Jovanovski and B. Kamenar, Cryst. Struct. Commun., 1982,(11), 247 CAS.
  24. CCDC 766997 (WURMOM): S. P. Velaga, V. R. Vangala, S. Basavoju and D. Bostrom, Chem. Commun., 2010, 46, 3562 RSC.
  25. CCDC 1198198 (KMOTZD), E. F. Paulus, Acta Crystallogr., Sect. B: Struct. Sci., 1975, 31, 1191 CrossRef.
  26. CCDC 650627 (RIFVIM): I. Leban, D. Rudan-Tasic, N. Lah and C. Klofutar, Acta Crystallogr., Sect. B: Struct. Sci., 2007, 63, 418 CrossRef CAS PubMed.
  27. CCDC 650628 (RIFVOS), I. Leban, D. Rudan-Tasic, N. Lah and C. Klofutar, Acta Crystallogr., Sect. B: Struct. Sci., 2007, 63, 418 CrossRef CAS PubMed.
  28. CCDC 1136816 (DAWGOX), M. Hatada, J. Jancarik, B. Graves and S.-H. Kim, J. Am. Chem. Soc., 1985, 107, 4279 CrossRef CAS.
  29. CCDC 608804 (KETXIR) C. Guguta, H. Meekes and R. de Gelder, Cryst. Growth Des., 2006, 6, 2686 CrossRef CAS.
  30. CCDC 1161343 (FUPFAX), C. H. Gorbitz, Acta Chem. Scand., 1987, 41, 87 CrossRef CAS PubMed.
  31. W. Dar, Int. Immunopharmacol., 2024, 135, 112295 CrossRef CAS PubMed.
  32. N. G. Gonçalves, E. Martinez-Steele, P. A. Lotufo, I. Bensenor, A. C. Goulart, S. M. Barreto, L. Giatti, C. Perim de Faria, M. del Carmen Bisi Molina, P. Caramelli, D. M. Marchioni and C. K. Suemoto, Neurology, 2025, 105, e214023 CrossRef PubMed.
  33. S. A. A. Shaher, D. F. Mihailescu and B. Amuzescu, Nutrients, 2023, 15, 3627 CrossRef CAS.
  34. W. Wu, W. Sui, S. Chen, Z. Guo, X. Jing, X. Wang, Q. Wang, X. Yu, W. Xiong, J. Ji, L. Yang, Y. Zhang, W. Jiang, G. Yu, S. Liu, W. Tao, C. Zhao, Y. Zhang, Y. Chen, C. Zhang and Y. Cao, Cell Metab., 2025, 37, 1075 CrossRef CAS PubMed.
  35. H. Bai, X. Zuo, C. Zhao, S. Zhang and X. Feng, J. Agric. Food Chem., 2024, 72, 23478 CrossRef CAS.
  36. F. Neese, The ORCA program system, Wiley Interdiscip. Rev.: Comput. Mol. Sci., 2012, 2, 73 CAS.
  37. F. Neese, F. Wennmohs, U. Becker and C. Riplinger, The ORCA quantum chemistry program package, J. Chem. Phys., 2020, 152, 224108 CrossRef CAS PubMed.
  38. F. Neese, ORCA – An ab initio, density functional and semi-empirical program package, version 5.0.4., 2022 Search PubMed.
  39. F. Weigend and R. Ahlrichs, Phys. Chem. Chem. Phys., 2005, 7, 3297 RSC.
  40. R. A. Kendall, T. H. Dunning Jr. and R. J. Harrison, J. Chem. Phys., 1992, 96, 6796 CrossRef CAS.
  41. F. Weigend, A. Kohn and C. Hattig, J. Chem. Phys., 2002, 116, 3175 CrossRef CAS.
  42. Y. Takano and K. N. Houk, J. Chem. Theory Comput., 2005, 1, 70 CrossRef PubMed.
  43. R. Boča, R. Imrich, J. Štofko, B. Vranovičová and C. Rajnák, Amino Acids, 2024, 56, 5 CrossRef.
  44. R. Boča, R. Imrich, J. Štofko, B. Vranovičová and C. Rajnák, J. Phys. Chem. A, 2024, 128, 8088 CrossRef PubMed.
  45. I. G. Binev, B. A. Stamboliyska and E. A. Velcheva, Spectrochim. Acta, Part A, 1996, A52, 1135 CrossRef.
  46. A. D. Popova, E. A. Velcheva and B. A. Stamboliyska, J. Mol. Struct., 2012, 1009, 23 CrossRef CAS.
  47. A. B. Brizuela, A. B. Raschi, M. V. Castillo, L. Davies, E. Romano and S. A. Brandán, J. Mol. Struct., 2014, 1074, 144 CrossRef CAS.
  48. S. Gunasekaran, P. Rajesh, T. Gnanasambandan, A. Manikandan and S. Seshadri, Int. J. Sci. Technol. Human., 2014, 1, 18 CrossRef.
  49. D. Dimič, D. Milenkovič, J. Dimitrič Markovič and Z. Markovič, Phys. Chem. Chem. Phys., 2017, 19, 12970 RSC.
  50. C.-G. Zhan and D. A. Dixon, J. Phys. Chem. A, 2001, 105, 11534 CrossRef CAS.
  51. F. R. Dutra, C. de Souza Silva and R. Custodio, J. Phys. Chem. A, 2021, 125, 65 CrossRef CAS PubMed.

This journal is © The Royal Society of Chemistry and the Centre National de la Recherche Scientifique 2026
Click here to see how this site uses Cookies. View our privacy policy here.